The Tribun Health executive team is growing with the creation of a VP Pharma position to develop the expanding pharmaceutical business.

OcyonBio CDMO welcomes cell and gene therapy expert Robert Salcedo who brings over 20 years of expertise in the areas of CMC, operations, and supply chain management and has served in multi-billion-dollar companies operating in biotech, vaccines, and pharmaceutical markets.

Factors such as a large population, rising incomes and expanding healthcare infrastructure are expected to allow more people in the emerging markets to afford western medication.